The population-level economic burden of liver cancer in China, 2019-2030: prevalence-based estimations from a societal perspective.

ABSTRACT:

Background

Benchmark data on the population-level economic burden are critical to inform policymakers about liver cancer control. However, comprehensive data in China are currently limited.

Methods

A prevalence-based approach from a societal perspective was used to quantify the annual economic burden of liver cancer in China from 2019 to 2030. Detailed per-case data on medical/non-medical expenditure and work-loss days were extracted from a multicenter survey. The numbers/rates of new/prevalent cases and deaths, survival, and population-related parameters were extracted from the Global Burden of Disease 2019 and the literature. All expenditure data were reported in both 2019 Chinese Yuan (CNY) and United States dollar (US$, for main estimations).

Result

The overall ec

SUBMITTER: Cao MD 

PROVIDER: S-EPMC9308023 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature